Acrisure Capital Management’s Labcorp LH Stock Holding History

Acrisure Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,529	Closed	-$301K	–	131
2023 Q1	$301K	Buy	+1,529	New	+$315K	0.31%	133

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Acrisure Capital Management's LH Position: Q2 2023 in Review

Acrisure Capital Management sold out of Labcorp (LH) in Q2 2023, closing a stake of 1,529 shares — an estimated $301K sold.

Acrisure Capital Management first reported a position in LH in Q1 2023 and held it in 1 quarter. The position peaked at $301K in Q1 2023. 932 funds tracked by Wall St. Rank hold LH as of Q2 2023.

Acrisure Capital Management reported no remaining Labcorp position as of Q2 2023 after selling out during the quarter.
Acrisure Capital Management sold 1,529 Labcorp shares in Q2 2023, an estimated $301K.
Acrisure Capital Management first reported a position in Labcorp in Q1 2023 and held it in 1 quarter.
Acrisure Capital Management's Labcorp position peaked at $301K in Q1 2023.
932 funds tracked by Wall St. Rank held Labcorp as of Q2 2023.

Based on Acrisure Capital Management's 13F filing for Q2 2023.